Skip to main content

Cannabis producer Hexo Corp. announced Friday that it grew marijuana in an unlicensed facility, but federal regulators cleared the company of any wrongdoing.

Gatineau-based Hexo said the problems occurred at a facility in Ontario’s Niagara region previously owned by Newstrike Brands Inc., which Hexo acquired in July. According to Hexo, Newstrike began growing cannabis at the site in November, 2018, after receiving what it believed to be the appropriate paperwork from Health Canada. Federal inspectors subsequently visited the site in February and raised no questions about the marijuana crop.

In July, shortly after the Newstrike acquisition closed, Hexo employees discovered the site was not adequately licensed. “Hexo management immediately ceased cultivation and production activities in the unlicensed space,” Hexo said Friday in a press release. It said: “The company notified Health Canada instantly, and the regulator was satisfied with Hexo management’s corrective actions.”

Story continues below advertisement

Hexo closed the Niagara facility in October as part of a cost-cutting initiative. On Friday, the company said: “Hexo is choosing to proactively address this occurrence now as it recently became aware of false information that was being circulated to damage the reputation of the company.”

Unlicensed cannabis production kicked off a scandal this summer that continues to haunt rival CannTrust Holdings Inc. The federal cannabis regulator suspended Vaughan, Ont.-based CannTrust’s growing and processing licences in September after investigators discovered the company grew thousands of kilograms of cannabis in unlicensed parts of its greenhouse facility in Pelham, Ont. CannTrust plans to destroy $77-million worth of cannabis in an attempt to get Health Canada to restore its licences. CannTrust’s share price has declined by 91 per cent since the beginning of the year and the company is effectively up for sale.

Your time is valuable. Have the Top Business Headlines newsletter conveniently delivered to your inbox in the morning or evening. Sign up today.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies